Increase of serum very low density lipoproteins in rats after administration of alpha-hexachlorocyclohexane

Naunyn Schmiedebergs Arch Pharmacol. 1977 Jun;298(2):129-35. doi: 10.1007/BF00508619.

Abstract

After enteral administration of 200 mg/kg alpha-hexachlorocyclohexane (alpha-HCH) female Wistar rats develop a hyperlipemia. 48 h after administration of alpha-HCH, serum triglycerides are increased by 300%, whereas both serum cholesterol and serum total phospholipids only increase by about 45%. Serum free fatty acids are not significantly altered. Fractionation of the serum lipoproteins by ultracentrifugation shows that the hyperlipemia is due to a fivefold increase in serum very low density lipoproteins. Hepatic triglyceride secretion, calculated after i.v. injection of Triton WR 1339, is increased in animals pretreated wtih alpha-HCH. Corresponding to this observation, drugs known to diminish the triglyceride secretion of the liver, such as actinomycin D, cycloheximide; glucagon, orotic acid, CFT 1201, and CFT 1042 reduce the alpha-HCH-induced hyperlipemia. We concluded from the results that hyperlipoproteinemia after alpha-HCH is due to an increased hepatic very low density lipoprotein secretion. At the same time, the blood sugar level was decreased in fasting animals after treatment with alpha-HCH. Earlier experiments suggest that this effect is due to a decreased gluconeogenesis in the liver.

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Fatty Acids, Nonesterified / blood
  • Female
  • Hexachlorocyclohexane / pharmacology*
  • Lipoproteins, VLDL / blood*
  • Rats
  • Stimulation, Chemical
  • Time Factors
  • Triglycerides / blood

Substances

  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Lipoproteins, VLDL
  • Triglycerides
  • Hexachlorocyclohexane